메뉴 건너뛰기




Volumn 14, Issue 10 SUPPL. 9, 2000, Pages 56-58

Preoperative UFT/ leucovorin and radiation therapy in rectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; FOLINIC ACID; TEGAFUR; URACIL;

EID: 0034304706     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (18)
  • 2
    • 0022876509 scopus 로고
    • Survival after postoperative combination treatment of rectal cancer
    • Douglas HO Jr, Moertel CG, Mayer RJ, et al: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315:1294-1295, 1986.
    • (1986) N Engl J Med , vol.315 , pp. 1294-1295
    • Douglas Jr., H.O.1    Moertel, C.G.2    Mayer, R.J.3
  • 3
    • 0026071185 scopus 로고
    • Effective surgical adjuvant therapy for high-risk rectal carcinoma
    • Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 19991.
    • (1991) N Engl J Med , vol.324 , pp. 709-715
    • Krook, J.E.1    Moertel, C.G.2    Gunderson, L.L.3
  • 4
    • 0028136295 scopus 로고
    • Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
    • O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994.
    • (1994) N Engl J Med , vol.331 , pp. 502-507
    • O'Connell, M.J.1    Martenson, J.A.2    Wieand, H.S.3
  • 5
    • 0026721532 scopus 로고
    • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rates
    • Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rates. J Clin Oncol 10:896-903, 1992.
    • (1992) J Clin Oncol , vol.10 , pp. 896-903
  • 6
    • 0030994521 scopus 로고    scopus 로고
    • Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114
    • Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 15:2030-2039, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 2030-2039
    • Tepper, J.E.1    O'Connell, M.J.2    Petroni, G.R.3
  • 7
    • 0032799672 scopus 로고    scopus 로고
    • Adjuvant postoperative combined-modality therapy for rectal cancer
    • Minsky BD: Adjuvant postoperative combined-modality therapy for rectal cancer. Oncology (Huntington) 13(suppl 3):132-135, 1999.
    • (1999) Oncology (Huntington) , vol.13 , Issue.3 SUPPL. , pp. 132-135
    • Minsky, B.D.1
  • 8
    • 0031017851 scopus 로고    scopus 로고
    • Patient preference for oral vs intravenous palliative chemotherapy
    • Liu G, Franssen E, Fitch MI, Warner E: Patient preference for oral vs intravenous palliative chemotherapy. J Clin Oncol 15:110-115, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 110-115
    • Liu, G.1    Franssen, E.2    Fitch, M.I.3    Warner, E.4
  • 9
    • 0031868962 scopus 로고    scopus 로고
    • UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer
    • Hoff PM, Pazdur R, Benner SE, et al: UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer. Anticancer Drugs 9:479-490, 1998.
    • (1998) Anticancer Drugs , vol.9 , pp. 479-490
    • Hoff, P.M.1    Pazdur, R.2    Benner, S.E.3
  • 10
    • 0027650899 scopus 로고
    • A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion vs oral UFT in plasma of same patients
    • Hirata K, Sasaki K, Yamamitsu S, Shiraska T: A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion vs oral UFT in plasma of same patients [in Japanese]. Jpn J Cancer Chemother 20:1409-1411, 1993.
    • (1993) Jpn J Cancer Chemother , vol.20 , pp. 1409-1411
    • Hirata, K.1    Sasaki, K.2    Yamamitsu, S.3    Shiraska, T.4
  • 11
    • 0031691506 scopus 로고    scopus 로고
    • Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil
    • Ho DH, Pazdur R, Covington W, et al: Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4:2085-2088, 1998.
    • (1998) Clin Cancer Res , vol.4 , pp. 2085-2088
    • Ho, D.H.1    Pazdur, R.2    Covington, W.3
  • 12
    • 0031043439 scopus 로고    scopus 로고
    • Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral 1-leucovorin
    • Okabe H, Toko T, Saito H, et al: Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral 1-leucovorin. Anticancer Res 17:157-164, 1997.
    • (1997) Anticancer Res , vol.17 , pp. 157-164
    • Okabe, H.1    Toko, T.2    Saito, H.3
  • 13
    • 0000082787 scopus 로고    scopus 로고
    • Multicenter phase III study of 5-fluorouracil (5-FU) UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer
    • abstract 1009
    • Pazdur R, Douillard J-Y, Skillings JR, et al: Multicenter phase III study of 5-fluorouracil (5-FU) UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer (abstract 1009). Proc Am Soc Clin Oncol 18:263, 1999.
    • (1999) Proc Am Soc Clin Oncol , vol.18 , pp. 263
    • Pazdur, R.1    Douillard, J.-Y.2    Skillings, J.R.3
  • 14
    • 0001073793 scopus 로고    scopus 로고
    • Randomized comparative study of ORZEL (oral uracil/tegafur [UFT] plus leucovorin [LV]) vs parenteral 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer
    • abstract 1015
    • Carmichael J, Popiela T, Radstone D, et al: Randomized comparative study of ORZEL (oral uracil/tegafur [UFT] plus leucovorin [LV]) vs parenteral 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer (abstract 1015). Proc Am Soc Clin Oncol 18:264a, 1999.
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Carmichael, J.1    Popiela, T.2    Radstone, D.3
  • 15
    • 0031671241 scopus 로고    scopus 로고
    • Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: Long- Term follow-up
    • Wagman R, Minsky BD, Cohen AM, et al: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: Long- term follow-up. Int J Radiat Oncol Biol Phys 42:51-57, 1998.
    • (1998) Int J Radiat Oncol Biol Phys , vol.42 , pp. 51-57
    • Wagman, R.1    Minsky, B.D.2    Cohen, A.M.3
  • 16
    • 0030975222 scopus 로고    scopus 로고
    • Infusional chemoradiation for operable rectal cancer: Post-, pre-, or nonoperative management?
    • Rich TA: Infusional chemoradiation for operable rectal cancer: Post-, pre-, or nonoperative management? Oncology (Huntington) 11:295-300, 1997.
    • (1997) Oncology (Huntington) , vol.11 , pp. 295-300
    • Rich, T.A.1
  • 17
    • 0031602151 scopus 로고    scopus 로고
    • Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis
    • Minsky BD: Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin Radial Oncol 8:30-35, 1998.
    • (1998) Semin Radial Oncol , vol.8 , pp. 30-35
    • Minsky, B.D.1
  • 18
    • 0028099423 scopus 로고
    • Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma
    • Pazdur R, Lassere Y, Rhodes V, et al: Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 2296-2300
    • Pazdur, R.1    Lassere, Y.2    Rhodes, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.